These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11201024)

  • 1. [Neurological events in patients with atrial fibrillation: outcome and preventive practices].
    Carlsson J; Miketic S; Flicker E; Erdogan A; Haun S; Cuneo A; Tebbe U
    Z Kardiol; 2000 Dec; 89(12):1090-7. PubMed ID: 11201024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study.
    Admassie E; Chalmers L; Bereznicki LR
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):329-336. PubMed ID: 29642709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients.
    Poli D; Antonucci E; Marcucci R; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D
    Int J Cardiol; 2009 Feb; 132(1):109-13. PubMed ID: 18180057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.
    Diener HC; Becher N; Sehner S; Toennis T; Bertaglia E; Blomstrom-Lundqvist C; Brandes A; Beuger V; Calvert M; Camm AJ; Chlouverakis G; Dan GA; Dichtl W; Fierenz A; Goette A; de Groot JR; Hermans A; Lip GYH; Lubinski A; Marijon E; Merkely B; Mont L; Nikorowitsch J; Ozga AK; Rajappan K; Sarkozy A; Scherr D; Schnabel RB; Schotten U; Simantirakis E; Vardas P; Wichterle D; Zapf A; Kirchhof P;
    J Am Heart Assoc; 2024 Sep; 13(17):e036429. PubMed ID: 39190564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke.
    Jung YH; Kim YD; Kim J; Han SW; Oh MS; Lee JS; Lee KY
    Stroke; 2020 Sep; 51(9):2733-2741. PubMed ID: 32811392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge.
    Tentschert S; Parigger S; Dorda V; Bittner K; Unterbuchschachner D; Greisenegger S; Wimmer R; Brücke T; Lang W; Lalouschek W;
    Wien Klin Wochenschr; 2004 Dec; 116(24):834-8. PubMed ID: 15690967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation.
    Yamashiro K; Kurita N; Tanaka R; Ueno Y; Miyamoto N; Hira K; Nakajima S; Urabe T; Hattori N
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1773-1780. PubMed ID: 30318259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome.
    Paciaroni M; Agnelli G; Caso V; Venti M; Milia P; Silvestrelli G; Parnetti L; Biagini S
    J Thromb Haemost; 2005 Jun; 3(6):1218-23. PubMed ID: 15892862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carotid atherosclerosis and risk for ischemic stroke in patients with atrial fibrillation on oral anticoagulant treatment.
    Becattini C; Dentali F; Camporese G; Sembolini A; Rancan E; Tonello C; Manina G; Padayattil S; Agnelli G
    Atherosclerosis; 2018 Apr; 271():177-181. PubMed ID: 29524860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-Stroke.
    Lewis WR; Fonarow GC; Grau-Sepulveda MV; Smith EE; Bhatt DL; Hernandez AF; Olson D; Peterson ED; Schwamm LH
    Am Heart J; 2011 Oct; 162(4):692-699.e2. PubMed ID: 21982662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study.
    Stöllberger C; Chnupa P; Abzieher C; Länger T; Finsterer J; Klem I; Hartl E; Wehinger C; Schneider B
    Clin Cardiol; 2004 Jan; 27(1):40-6. PubMed ID: 14743856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA.
    Wilson D; Ambler G; Shakeshaft C; Banerjee G; Charidimou A; Seiffge D; White M; Cohen H; Yousry T; Salman R AS; Lip GYH; Muir K; Brown MM; Jäger HR; Werring DJ;
    BMJ Open; 2019 Jul; 9(7):e028387. PubMed ID: 31345970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke.
    Lip GY; Hunter TD; Quiroz ME; Ziegler PD; Turakhia MP
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.
    Bakhai A; Darius H; De Caterina R; Smart A; Le Heuzey JY; Schilling RJ; Zamorano JL; Shah M; Bramlage P; Kirchhof P
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):299-305. PubMed ID: 29474715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
    Golive A; May HT; Bair TL; Jacobs V; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2017 Jul; 120(1):75-82. PubMed ID: 28483209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation.
    Liang JJ; Elafros MA; Mullen MT; Muser D; Hayashi T; Enriquez A; Pathak RK; Zado ES; Santangeli P; Arkles JS; Schaller RD; Supple GE; Frankel DS; Garcia FC; Deo R; Lin D; Riley MP; Nazarian S; Dixit S; Marchlinski FE; Callans DJ
    J Cardiovasc Electrophysiol; 2018 Jun; 29(6):823-832. PubMed ID: 29513397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.